FindTrial
Sign In

A Study on Awareness, Opinions, and Use of Pneumococcal Vaccine Among Indian Doctors Treating Diabetes

A Cross-Sectional Survey on Knowledge, Attitude, and Practice (KAP) Towards Pneumococcal Vaccination Among Indian Endocrinologists and Diabetologists. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/12/098399
Enrollment
500
Registered
2025-12-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil

Sponsors

Academic Survey
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Endocrinologists or diabetologists practising in India (MD/DNB/DM) Minimum 3 years of clinical experience

Exclusion criteria

Exclusion criteria: Not willing to provide informed consent to participate in the online survey

Design outcomes

Primary

MeasureTime frame
Proportion of endocrinologists and diabetologists demonstrating adequate knowledge, positive attitudes, and appropriate clinical practices (KAP) regarding pneumococcal vaccination in adult persons living with diabetes, as measured by a structured, validated KAP questionnaireTimepoint: 13 weeks—

Secondary

MeasureTime frame
Barriers & Facilitators to Vaccination Advocacy Proportion of respondents reporting key barriers (e.g., cost, awareness, patient compliance) & facilitators (e.g., updated guidelines, availability of PCV20), & their influence on pneumococcal vaccine recommendation & uptake.Timepoint: 13 weeks—

Countries

India

Contacts

Public ContactDr Sanjay Kalra

Bharti Hospital

brideknl@gmail.com9896048555

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026